Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has focused attention on AIDS-related cancers including Kaposi sarcoma (KS). However, the effect of KS on response to ART is not well-described in Southern Africa. We assessed the effect of KS on survival and immunologic and virologic treatment responses at 6- and 12-months after initiation of ART
Kaposi’s sarcoma (KS) is an AIDS-defining malignancy that can improve or worsen with antiretroviral ...
Awaiting permission from the publisher.The risk of Kaposi sarcoma (KS) among HIV-infected persons on...
SummaryObjectiveTo retrospectively investigate the outcomes of patients with AIDS-associated Kaposi ...
Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has focused attenti...
BACKGROUND Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has foc...
Background: Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has foc...
Background. When South Africa (SA) implemented its antiretroviral therapy (ART) programme in 2004, t...
BACKGROUND : When South Africa (SA) implemented its antiretroviral therapy (ART) programme in 2004, ...
AIDS-associated Kaposi's sarcoma (KS) is the most common AIDS-related malignancy in sub-Saharan Afri...
BACKGROUND The possible impact of coinfection with the Kaposi sarcoma-associated herpes virus (KSHV...
BACKGROUND When South Africa (SA) implemented its antiretroviral therapy (ART) programme in 2004,...
With great interest, we read the recent publication “Kaposi’s sarcoma in HIV-infected patients in So...
HIV-associated/epidemic Kaposi's sarcoma (EpKS) is an AIDS-defining angio-proliferative malignancy. ...
BACKGROUND The risk of Kaposi sarcoma (KS) among HIV-infected persons on antiretroviral therapy (...
Kaposi sarcoma (KS) gained public attention as an AIDS-defining malignancy; its appearance on t...
Kaposi’s sarcoma (KS) is an AIDS-defining malignancy that can improve or worsen with antiretroviral ...
Awaiting permission from the publisher.The risk of Kaposi sarcoma (KS) among HIV-infected persons on...
SummaryObjectiveTo retrospectively investigate the outcomes of patients with AIDS-associated Kaposi ...
Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has focused attenti...
BACKGROUND Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has foc...
Background: Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has foc...
Background. When South Africa (SA) implemented its antiretroviral therapy (ART) programme in 2004, t...
BACKGROUND : When South Africa (SA) implemented its antiretroviral therapy (ART) programme in 2004, ...
AIDS-associated Kaposi's sarcoma (KS) is the most common AIDS-related malignancy in sub-Saharan Afri...
BACKGROUND The possible impact of coinfection with the Kaposi sarcoma-associated herpes virus (KSHV...
BACKGROUND When South Africa (SA) implemented its antiretroviral therapy (ART) programme in 2004,...
With great interest, we read the recent publication “Kaposi’s sarcoma in HIV-infected patients in So...
HIV-associated/epidemic Kaposi's sarcoma (EpKS) is an AIDS-defining angio-proliferative malignancy. ...
BACKGROUND The risk of Kaposi sarcoma (KS) among HIV-infected persons on antiretroviral therapy (...
Kaposi sarcoma (KS) gained public attention as an AIDS-defining malignancy; its appearance on t...
Kaposi’s sarcoma (KS) is an AIDS-defining malignancy that can improve or worsen with antiretroviral ...
Awaiting permission from the publisher.The risk of Kaposi sarcoma (KS) among HIV-infected persons on...
SummaryObjectiveTo retrospectively investigate the outcomes of patients with AIDS-associated Kaposi ...